Drug Resistance, Bacterial

"Drug Resistance, Bacterial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).

Descriptor ID	D024881
MeSH Number(s)	G06.099.225 G06.225.347 G07.690.773.984.269.347
Concept/Terms	Drug Resistance, Bacterial Drug Resistance, Bacterial Antibacterial Drug Resistance Antibiotic Resistance, Bacterial Antibiotic Resistance, Bacterial

Below are MeSH descriptors whose meaning is more general than "Drug Resistance, Bacterial".

Biological Sciences [G]
Microbiological Phenomena [G06]
Bacterial Physiological Phenomena [G06.099]
Drug Resistance, Bacterial [G06.099.225]
Drug Resistance, Microbial [G06.225]
Drug Resistance, Bacterial [G06.225.347]
Physiological Phenomena [G07]
Pharmacological and Toxicological Phenomena [G07.690]
Pharmacological Phenomena [G07.690.773]
Drug Resistance [G07.690.773.984]
Drug Resistance, Microbial [G07.690.773.984.269]
Drug Resistance, Bacterial [G07.690.773.984.269.347]

Below are MeSH descriptors whose meaning is related to "Drug Resistance, Bacterial".

Below are MeSH descriptors whose meaning is more specific than "Drug Resistance, Bacterial".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Drug Resistance, Bacterial" by people in this website by year, and whether "Drug Resistance, Bacterial" was a major or minor topic of these publications.

Bar chart showing 78 publications over 23 distinct years, with a maximum of 7 publications in 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	0	5	5
2004	2	1	3
2005	0	2	2
2006	3	3	6
2007	0	3	3
2008	1	0	1
2009	1	0	1
2010	2	1	3
2011	1	1	2
2012	2	0	2
2013	4	3	7
2014	2	2	4
2015	2	4	6
2016	2	2	4
2017	3	0	3
2018	2	2	4
2019	4	2	6
2020	2	2	4
2021	2	2	4
2022	0	3	3
2023	0	1	1
2024	1	1	2
2025	0	2	2

Below are the most recent publications written about "Drug Resistance, Bacterial" by people in Profiles.

Hikal AF, Zhao S, Foley S, Khan AA. The newly identified grdA gene confers high-level plazomicin resistance in Salmonella enterica serovars. Antimicrob Agents Chemother. 2025 05 07; 69(5):e0160624.

View in: PubMed
Luna MJ, Oluoch PO, Miao J, Culviner P, Papavinasasundaram K, Jaecklein E, Shell SS, Ioerger TR, Fortune SM, Farhat MR, Sassetti CM. Frequently arising ESX-1-associated phase variants influence Mycobacterium tuberculosis fitness in the presence of host and antibiotic pressures. mBio. 2025 Mar 12; 16(3):e0376224.

View in: PubMed
Lee CC, Lai CH, Lin SY, Lee NY, Liu PY, Yang CH, Huang YH, Lin JN. In?vitro induction and selection of fluoroquinolone-resistant mutants in Elizabethkingia anophelis. J Microbiol Immunol Infect. 2024 Oct; 57(5):822-826.

View in: PubMed
Bhattarai SK, Du M, Zeamer AL, M Morzfeld B, Kellogg TD, Firat K, Benjamin A, Bean JM, Zimmerman M, Mardi G, Vilbrun SC, Walsh KF, Fitzgerald DW, Glickman MS, Bucci V. Commensal antimicrobial resistance mediates microbiome resilience to antibiotic disruption. Sci Transl Med. 2024 01 17; 16(730):eadi9711.

View in: PubMed
Xie M, Gao M, Yun Y, Malmsten M, Rotello VM, Zboril R, Akhavan O, Kraskouski A, Amalraj J, Cai X, Lu J, Zheng H, Li R. Antibacterial Nanomaterials: Mechanisms, Impacts on Antimicrobial Resistance and Design Principles. Angew Chem Int Ed Engl. 2023 04 17; 62(17):e202217345.

View in: PubMed
Rowlinson E, Soge OO, Hughes JP, Berzkalns A, Thibault C, Kerani RP, Khosropour CM, Manhart LE, Golden MR, Barbee LA. Prior Exposure to Azithromycin and Azithromycin Resistance Among Persons Diagnosed With Neisseria gonorrhoeae Infection at a Sexual Health Clinic: 2012-2019. Clin Infect Dis. 2023 02 08; 76(3):e1270-e1276.

View in: PubMed
Rothberg MB, Haessler S, Deshpande A, Yu PC, Lindenauer PK, Zilberberg MD, Higgins TL, Imrey PB. Derivation and validation of a risk assessment model for drug-resistant pathogens in hospitalized patients with community-acquired pneumonia. Infect Control Hosp Epidemiol. 2023 07; 44(7):1143-1150.

View in: PubMed
Lin IF, Lai CH, Lin SY, Lee CC, Lee NY, Liu PY, Yang CH, Huang YH, Lin JN. Mutant Prevention Concentrations of Ciprofloxacin and Levofloxacin and Target Gene Mutations of Fluoroquinolones in Elizabethkingia anophelis. Antimicrob Agents Chemother. 2022 07 19; 66(7):e0030122.

View in: PubMed
Li X, Le W, Lou X, Genco CA, Rice PA, Su X. In Vitro Activity of Ertapenem against Neisseria gonorrhoeae Clinical Isolates with Decreased Susceptibility or Resistance to Extended-Spectrum Cephalosporins in Nanjing, China (2013 to 2019). Antimicrob Agents Chemother. 2022 05 17; 66(5):e0010922.

View in: PubMed
Bettoni S, Maziarz K, Stone MRL, Blaskovich MAT, Potempa J, Bazzo ML, Unemo M, Ram S, Blom AM. Serum Complement Activation by C4BP-IgM Fusion Protein Can Restore Susceptibility to Antibiotics in Neisseria gonorrhoeae. Front Immunol. 2021; 12:726801.

View in: PubMed

People

Explore

Similar Concepts

Top Journals